Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria

Antimicrobial resistance poses a major threat to public health. Given the paucity of novel antimicrobials to treat resistant infections, the emergence of multidrug-resistant bacteria renewed interest in antimicrobial peptides as potential therapeutics. This study designed a new analog of the antimic...

Full description

Bibliographic Details
Main Authors: Gabriela Marinho Righetto, José Luiz de Souza Lopes, Paulo José Martins Bispo, Camille André, Julia Medeiros Souza, Adriano Defini Andricopulo, Leila Maria Beltramini, Ilana Lopes Baratella da Cunha Camargo
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/2/391
_version_ 1827758964411990016
author Gabriela Marinho Righetto
José Luiz de Souza Lopes
Paulo José Martins Bispo
Camille André
Julia Medeiros Souza
Adriano Defini Andricopulo
Leila Maria Beltramini
Ilana Lopes Baratella da Cunha Camargo
author_facet Gabriela Marinho Righetto
José Luiz de Souza Lopes
Paulo José Martins Bispo
Camille André
Julia Medeiros Souza
Adriano Defini Andricopulo
Leila Maria Beltramini
Ilana Lopes Baratella da Cunha Camargo
author_sort Gabriela Marinho Righetto
collection DOAJ
description Antimicrobial resistance poses a major threat to public health. Given the paucity of novel antimicrobials to treat resistant infections, the emergence of multidrug-resistant bacteria renewed interest in antimicrobial peptides as potential therapeutics. This study designed a new analog of the antimicrobial peptide Plantaricin 149 (Pln149-PEP20) based on previous Fmoc-peptides. The minimal inhibitory concentrations of Pln149-PEP20 were determined for 60 bacteria of different species and resistance profiles, ranging from 1 mg/L to 128 mg/L for Gram-positive bacteria and 16 to 512 mg/L for Gram-negative. Furthermore, Pln149-PEP20 demonstrated excellent bactericidal activity within one hour. To determine the propensity to develop resistance to Pln149-PEP20, a directed-evolution in vitro experiment was performed. Whole-genome sequencing of selected mutants with increased MICs and wild-type isolates revealed that most mutations were concentrated in genes associated with membrane metabolism, indicating the most likely target of Pln149-PEP20. Synchrotron radiation circular dichroism showed how this molecule disturbs the membranes, suggesting a carpet mode of interaction. Membrane depolarization and transmission electron microscopy assays supported these two hypotheses, although a secondary intracellular mechanism of action is possible. The molecule studied in this research has the potential to be used as a novel antimicrobial therapy, although further modifications and optimization remain possible.
first_indexed 2024-03-11T09:15:01Z
format Article
id doaj.art-5ea26b3cbc744a11b6e6a5110858fbec
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-11T09:15:01Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-5ea26b3cbc744a11b6e6a5110858fbec2023-11-16T18:44:23ZengMDPI AGAntibiotics2079-63822023-02-0112239110.3390/antibiotics12020391Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant BacteriaGabriela Marinho Righetto0José Luiz de Souza Lopes1Paulo José Martins Bispo2Camille André3Julia Medeiros Souza4Adriano Defini Andricopulo5Leila Maria Beltramini6Ilana Lopes Baratella da Cunha Camargo7Laboratory of Molecular Epidemiology and Microbiology, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, BrazilLaboratory of Applied Biophysics, Department of Applied Physics, Institute of Physics, University of São Paulo, São Paulo 05315-970, BrazilDepartment of Ophthalmology, Infectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02115, USADepartment of Ophthalmology, Infectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02115, USALaboratory of Medicinal and Computational Chemistry, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, BrazilLaboratory of Medicinal and Computational Chemistry, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, BrazilGroup of Biophysics and Structural Biology “Sérgio Mascarenhas”, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, BrazilLaboratory of Molecular Epidemiology and Microbiology, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, BrazilAntimicrobial resistance poses a major threat to public health. Given the paucity of novel antimicrobials to treat resistant infections, the emergence of multidrug-resistant bacteria renewed interest in antimicrobial peptides as potential therapeutics. This study designed a new analog of the antimicrobial peptide Plantaricin 149 (Pln149-PEP20) based on previous Fmoc-peptides. The minimal inhibitory concentrations of Pln149-PEP20 were determined for 60 bacteria of different species and resistance profiles, ranging from 1 mg/L to 128 mg/L for Gram-positive bacteria and 16 to 512 mg/L for Gram-negative. Furthermore, Pln149-PEP20 demonstrated excellent bactericidal activity within one hour. To determine the propensity to develop resistance to Pln149-PEP20, a directed-evolution in vitro experiment was performed. Whole-genome sequencing of selected mutants with increased MICs and wild-type isolates revealed that most mutations were concentrated in genes associated with membrane metabolism, indicating the most likely target of Pln149-PEP20. Synchrotron radiation circular dichroism showed how this molecule disturbs the membranes, suggesting a carpet mode of interaction. Membrane depolarization and transmission electron microscopy assays supported these two hypotheses, although a secondary intracellular mechanism of action is possible. The molecule studied in this research has the potential to be used as a novel antimicrobial therapy, although further modifications and optimization remain possible.https://www.mdpi.com/2079-6382/12/2/391Plantaricin 149synergismcarpet-like mechanism
spellingShingle Gabriela Marinho Righetto
José Luiz de Souza Lopes
Paulo José Martins Bispo
Camille André
Julia Medeiros Souza
Adriano Defini Andricopulo
Leila Maria Beltramini
Ilana Lopes Baratella da Cunha Camargo
Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
Antibiotics
Plantaricin 149
synergism
carpet-like mechanism
title Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
title_full Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
title_fullStr Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
title_full_unstemmed Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
title_short Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
title_sort antimicrobial activity of an fmoc plantaricin 149 derivative peptide against multidrug resistant bacteria
topic Plantaricin 149
synergism
carpet-like mechanism
url https://www.mdpi.com/2079-6382/12/2/391
work_keys_str_mv AT gabrielamarinhorighetto antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT joseluizdesouzalopes antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT paulojosemartinsbispo antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT camilleandre antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT juliamedeirossouza antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT adrianodefiniandricopulo antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT leilamariabeltramini antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria
AT ilanalopesbaratelladacunhacamargo antimicrobialactivityofanfmocplantaricin149derivativepeptideagainstmultidrugresistantbacteria